![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Dr_Salvador_Moncada.jpg/640px-Dr_Salvador_Moncada.jpg&w=640&q=50)
Salvador Moncada
Honduran pharmacologist and professor / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Salvador Moncada?
Summarize this article for a 10 year old
Sir Salvador Enrique Moncada Seidner, FRS, FRCP, FMedSci (born 3 December 1944) is a Honduran-British pharmacologist and professor. He is currently Research Domain Director for Cancer at the University of Manchester.[3]
Sir Salvador Moncada | |
---|---|
![]() | |
Born | (1944-12-03) 3 December 1944 (age 79) |
Other names | Salvador Enrique Moncada Seidner |
Citizenship | United Kingdom Honduras |
Alma mater | |
Known for | Prostacyclin |
Spouses |
|
Children | 4 |
Awards | |
Scientific career | |
Fields | Pharmacology |
Institutions | |
Website | manchester |
In the past, he was the Research Director of the Wellcome Research Laboratories from 1986 to 1995 and, until recently, the Director of the UCL Wolfson Institute, which he established at University College London in 1996. His research interests include inflammation and vascular biology and he is currently working on the regulation of cell proliferation. He gained fame for his discoveries related to nitric oxide function and metabolism, and his exclusion from the 1996 Lasker Award and the 1998 Nobel Prize in medicine.[4][5][6][7][8][9][10]
Sir Salvador was nominated by Xiomara Castro, the President of Honduras, to serve as their first Ambassador to China following the Honduran government's recognition of the People's Republic of China in March 2023. The Embassy in Beijing is due to be opened when President Castro visits in June 2023.[11]